Calliditas Therapeutics AB (publ) (CALT) Stock Chart & Stock Price History $40.00 0.00 (0.00%) (As of 10/31/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Calliditas Therapeutics AB (publ) Stock Price Performance5 Day PerformanceN/A1 Month PerformanceN/A3 Month Performance+4.03%6 Month Performance+106.08%Year-To-Date Performance+55.38%1 Year Performance+145.40% Receive CALT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Calliditas Therapeutics AB (publ) and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyBanking failure dead aheadIf you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. CALT Stock Chart for Thursday, October, 31, 2024 CALT Chart by TradingView Calliditas Therapeutics AB (publ) Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/20/2024$40.04$40.12+0.20%$43.00$40.009,796 shs$1.20 billion09/19/2024$40.03$40.04+0.02%$40.55$40.045,088 shs$1.19 billion09/18/2024$40.20$40.03-0.42%$40.80$39.566,039 shs$1.19 billion09/17/2024$40.31$40.20-0.27%$40.34$39.99964 shs$1.20 billion09/16/2024$40.00$40.31+0.78%$40.75$40.093,062 shs$1.20 billion09/13/2024$39.80$40.00+0.50%$40.24$39.044,324 shs$1.20 billion Get the Latest News and Ratings for CALT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Calliditas Therapeutics AB (publ) and its competitors with MarketBeat's FREE daily newsletter. 09/12/2024$39.80$39.80$39.80$39.80616 shs$1.19 billion09/11/2024$39.78$39.80+0.05%$40.28$39.803,388 shs$1.19 billion09/10/2024$39.78$39.78$40.07$39.781,336 shs$1.19 billion09/09/2024$40.75$39.78-2.38%$40.28$39.7110,613 shs$1.19 billion09/06/2024$40.26$40.75+1.22%$41.31$40.0022,663 shs$1.21 billion09/05/2024$40.24$40.26+0.05%$40.50$39.699,712 shs$1.20 billion09/04/2024$41.55$40.24-3.15%$41.50$39.7118,134 shs$1.21 billion09/03/2024$40.12$41.55+3.56%$42.06$40.0611,806 shs$1.25 billion09/02/2024$40.12$40.12$40.14$39.694,400 shs$1.20 billion08/30/2024$40.52$40.12-0.99%$40.14$39.694,417 shs$1.20 billion08/29/2024$40.50$40.52+0.05%$40.52$40.253,792 shs$1.21 billion08/28/2024$40.51$40.50-0.02%$40.70$40.257,787 shs$1.21 billion08/27/2024$40.36$40.51+0.37%$41.05$40.3534,106 shs$1.21 billion08/26/2024$40.47$40.36-0.27%$41.50$40.3111,997 shs$1.21 billion08/23/2024$40.30$40.47+0.42%$40.75$40.1710,571 shs$1.21 billion08/22/2024$40.54$40.30-0.59%$40.59$40.303,227 shs$1.20 billion08/21/2024$40.41$40.54+0.32%$40.59$40.0516,035 shs$1.21 billion08/20/2024$39.25$40.41+2.96%$40.88$39.7932,259 shs$1.20 billion08/19/2024$39.32$39.25-0.18%$40.10$39.2423,627 shs$1.17 billion08/16/2024$38.96$39.32+0.92%$39.49$39.2413,062 shs$1.17 billion08/15/2024$39.21$38.96-0.64%$39.39$35.7739,872 shs$1.16 billion08/14/2024$39.25$39.21-0.10%$39.80$39.205,635 shs$1.17 billion08/13/2024$39.18$39.25+0.17%$39.67$39.206,143 shs$1.17 billion08/12/2024$39.61$39.18-1.08%$39.25$38.805,435 shs$1.17 billion08/09/2024$39.16$39.61+1.15%$39.67$38.695,476 shs$1.18 billion08/08/2024$39.74$39.16-1.46%$39.18$38.587,779 shs$1.17 billion08/07/2024$39.10$39.74+1.64%$39.74$38.952,627 shs$1.18 billion08/06/2024$38.91$39.10+0.49%$39.25$38.593,315 shs$1.16 billion08/05/2024$38.78$38.91+0.34%$39.15$38.913,393 shs$1.16 billion08/02/2024$38.31$38.65+0.89%$39.18$38.5513,482 shs$1.15 billion08/01/2024$38.45$38.31-0.36%$38.70$38.319,693 shs$1.14 billion07/31/2024$37.67$38.45+2.07%$38.55$37.7713,586 shs$1.15 billion07/30/2024$38.00$37.67-0.87%$38.30$37.662,996 shs$1.12 billion Related Companies Travere Therapeutics Stock Price Chart Enanta Pharmaceuticals Stock Price Chart Omeros Stock Price Chart Crinetics Pharmaceuticals Stock Price Chart BridgeBio Pharma Stock Price Chart Cybin Stock Price Chart Biohaven Stock Price Chart Organon & Co. Stock Price Chart Immunovant Stock Price Chart TG Therapeutics Stock Price Chart Receive CALT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Calliditas Therapeutics AB (publ) and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CALT) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Calliditas Therapeutics AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share Calliditas Therapeutics AB (publ) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
